Salvage Surgery With Organ Preservation for Patients With Local Regrowth After Watch and Wait: Is It Still Possible?

被引:31
作者
Fernandez, Laura M. [1 ]
Figueiredo, Nuno L. [1 ]
Habr-Gama, Angelita [2 ,3 ]
Sao Juliao, Guilherme P. [2 ]
Vieira, Pedro [1 ]
Vailati, Bruna B. [2 ]
Nasir, Irfan [1 ]
Pares, Oriol [1 ]
Santiago, Ines [1 ]
Castillo-Martin, Mireia [1 ]
Carvalho, Carlos [1 ]
Parvaiz, Amjad [1 ]
Perez, Rodrigo Oliva [1 ,2 ,3 ,4 ]
机构
[1] Champalimaud Fdn, Lisbon, Portugal
[2] Angelita & Joaquim Gama Inst, Sao Paulo, Brazil
[3] Univ Sao Paulo, Colorectal Surg Div, Sch Med, Sao Paulo, Brazil
[4] Ludwig Inst Canc Res, Sao Paulo Branch, Sao Paulo, Brazil
关键词
Local regrowth; Organ preservation; Salvage surgery; Watch and wait; DISTAL RECTAL-CANCER; EXTENDED NEOADJUVANT CHEMORADIATION; THERAPY; IMPACT; MULTICENTER; OUTCOMES;
D O I
10.1097/DCR.0000000000001707
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND: Patients with rectal cancer who achieve complete clinical response after neoadjuvant chemoradiation have been managed nonoperatively. Thirty percent of these patients may develop a local regrowth, and salvage resection with radical surgery is usually recommended. However, selected patients could be offered additional organ preservation by local excision. We hypothesized that patients with baseline T2 who underwent neoadjuvant therapy (for the specific purpose of achieving a complete clinical response) were more likely to harbor recurrent disease at an earlier stage and amenable to organ preservation strategies (local excision) when compared with T3/T4 (undergoing neoadjuvant chemoradiation for oncologic reasons). OBJECTIVE: The purpose of this study was to compare patients with local regrowth requiring salvage resection according to their baseline stage. DESIGN: This was a retrospective review of consecutive patients with nonmetastatic distal rectal cancer undergoing neoadjuvant chemoradiation. SETTINGS: The study included 2 independent tertiary centers with institutional watch-and-wait organ preservation programs. PATIENTS: Consecutive patients with distal rectal cancer (cT2-4N1-2M0) managed by watch and wait and local regrowth from 2 institutions were included. MAIN OUTCOMES MEASURES: Final pathologic features and surgical and oncologic outcomes were compared according to baseline staging. RESULTS: A total of 73 of 257 patients experienced local regrowth. cT2 presented similar to ypT, ypN, R0, and abdominal perineal resection rates (p> 0.05) at the time of salvage when compared with cT3 to cT4. Patients with cT2 at baseline were more likely to undergo an organ preservation procedure for salvage (56.2% vs 26.5%;p= 0.03). Overall and disease-free survival after salvage were similar between groups irrespective of the type of surgery for the regrowth. LIMITATIONS: Retrospective study, small sample size, and possible inaccurate baseline staging. CONCLUSIONS: Although patients with baseline cT2 rectal cancer had similar pathologic stage at the time of recurrence, these patients were more likely to continue an organ preservation pathway after local regrowth through transanal local excision when compared with cT3 to cT4. Despite differences in the use of radical salvage resection, there were no differences in oncologic outcomes.
引用
收藏
页码:1053 / 1062
页数:10
相关论文
共 24 条
[1]   High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study [J].
Appelt, Ane L. ;
Ploen, John ;
Harling, Henrik ;
Jensen, Frank S. ;
Jensen, Lars H. ;
Jorgensen, Jens C. R. ;
Lindebjerg, Jan ;
Rafaelsen, Soren R. ;
Jakobsen, Anders .
LANCET ONCOLOGY, 2015, 16 (08) :919-927
[2]   Rectal cancer: Local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging - A meta-analysis [J].
Bipat, S ;
Glas, AS ;
Slors, FJM ;
Zwinderman, AH ;
Bossuyt, PMM ;
Stoker, J .
RADIOLOGY, 2004, 232 (03) :773-783
[3]   Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis [J].
Chadi, Sami A. ;
Malcomson, Lee ;
Ensor, Joie ;
Riley, Richard D. ;
Vaccaro, Carlos A. ;
Rossi, Gustavo L. ;
Daniels, Ian R. ;
Smart, Neil J. ;
Osborne, Melanie E. ;
Beets, Geerard L. ;
Maas, Monique ;
Bitterman, Danielle S. ;
Du, Kevin ;
Gollins, Simon ;
Myint, Arthur Sun ;
Smith, Fraser M. ;
Saunders, Mark P. ;
Scott, Nigel ;
O'Dwyer, Sarah T. ;
Araujo, Rodrigo Otavio de Castro ;
Valadao, Marcus ;
Lopes, Alberto ;
Hsiao, Cheng-Wen ;
Lai, Chien-Liang ;
Smith, Radhika K. ;
Paulson, Emily Carter ;
Appelt, Ane ;
Jakobsen, Anders ;
Wexner, Steven D. ;
Habr-Gama, Angelita ;
Juliao, Guilherme Sao ;
Perez, Rodiguo ;
Renehan, Andrew G. .
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2018, 3 (12) :825-836
[4]   Oncological and Survival Outcomes in Watch and Wait Patients With a Clinical Complete Response After Neoadjuvant Chemoradiotherapy for Rectal Cancer A Systematic Review and Pooled Analysis [J].
Dattani, Mit ;
Heald, Richard J. ;
Goussous, Ghaleb ;
Broadhurst, Jack ;
Sao Juliao, Guilherme P. ;
Habr-Gama, Angelita ;
Perez, Rodrigo Oliva ;
Moran, Brendan J. .
ANNALS OF SURGERY, 2018, 268 (06) :955-967
[5]   A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis [J].
Dossa, Fahima ;
Chesney, Tyler R. ;
Acuna, Sergio A. ;
Baxter, Nancy N. .
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (07) :501-513
[6]   Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial [J].
Garcia-Aguilar, Julio ;
Chow, Oliver S. ;
Smith, David D. ;
Marcet, Jorge E. ;
Cataldo, Peter A. ;
Varma, Madhulika G. ;
Kumar, Anjali S. ;
Oommen, Samuel ;
Coutsoftides, Theodore ;
Hunt, Steven R. ;
Stamos, Michael J. ;
Ternent, Charles A. ;
Herzig, Daniel O. ;
Fichera, Alessandro ;
Polite, Blase N. ;
Dietz, David W. ;
Patil, Sujata ;
Avila, Karin .
LANCET ONCOLOGY, 2015, 16 (08) :957-966
[7]   A Phase II Trial of Neoadjuvant Chemoradiation and Local Excision for T2N0 Rectal Cancer: Preliminary Results of the ACOSOG Z6041 Trial [J].
Garcia-Aguilar, Julio ;
Shi, Qian ;
Thomas, Charles R., Jr. ;
Chan, Emily ;
Cataldo, Peter ;
Marcet, Jorge ;
Medich, David ;
Pigazzi, Alessio ;
Oommen, Samuel ;
Posner, Mitchell C. .
ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (02) :384-391
[8]   Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy - Long-term results [J].
Habr-Gama, A ;
Perez, RO ;
Nadalin, W ;
Sabbaga, J ;
Ribeiro, U ;
Sousa, AHSE ;
Campos, FG ;
Kiss, DR ;
Gama-Rodrigues, J .
ANNALS OF SURGERY, 2004, 240 (04) :711-717
[9]   Interval between surgery and neoadjuvant chemoradiation therapy for distal rectal cancer: Does delayed surgery have an impact on outcome? [J].
Habr-Gama, Angelita ;
Perez, Rodrigo Oliva ;
Proscurshim, Igor ;
Nunes dos Santos, Rafael Miyashiro ;
Kiss, Desiderio ;
Gama-Rodrigues, Joaquin ;
Cecconello, Ivan .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (04) :1181-1188
[10]   Organ Preservation Among Patients With Clinically Node-Positive Rectal Cancer: Is It Really More Dangerous? [J].
Habr-Gama, Angelita ;
Sao Juliao, Guilherme Pagin ;
Vailati, Bruna Borba ;
Fernandez, Laura M. ;
Ortega, Cinthia D. ;
Figueiredo, Nuno ;
Gama-Rodrigues, Joaquim ;
Perez, Rodrigo Oliva .
DISEASES OF THE COLON & RECTUM, 2019, 62 (06) :675-683